Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene expression profiling in polycythemia vera using cDNA microarray technology.

Andrea Pellagatti1, David Vetrie, Cordelia F Langford

  • 1Leukaemia Research Fund, Molecular Haematology Unit, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom.

Cancer Research
|July 23, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chromatin rewiring of β-globin and MYC enhancers by TGF-β1 drives defective erythropoiesis.

Nature communications·2026
Same author

Ribosomal protein control of hematopoietic stem cell transformation through regulation of metabolism.

Cell reports·2025
Same author

Induced pluripotent stem cell-based modelling of disease evolution in myeloid leukemia: MDS to AML.

Advances in biological regulation·2025
Same author

A precision medicine approach to the myelodysplastic syndrome with isolated deletion 5q, 50 years after its discovery.

Blood·2025
Same author

Splicing of erythroid transcription factor is associated with therapeutic response in myelodysplastic syndromes.

The Journal of clinical investigation·2025
Same author

Reducing clinical trial eligibility barriers for patients with MDS: an icMDS position statement.

Blood·2025

Polycythemia vera (PV), a myeloproliferative disorder, shows distinct gene expression changes in granulocytes. These alterations, including up-regulated protease inhibitors and antiapoptotic factors, may explain abnormal cell survival in PV patients.

Area of Science:

  • Hematology
  • Molecular Biology
  • Genomics

Background:

  • Polycythemia vera (PV) is a myeloproliferative neoplasm.
  • The underlying molecular mechanisms driving PV pathogenesis remain largely unknown.
  • Understanding gene expression profiles can elucidate disease mechanisms.

Purpose of the Study:

  • To investigate the gene expression profile of granulocytes in Polycythemia vera (PV) patients.
  • To identify potential molecular signatures and pathogenetic pathways in PV.
  • To compare gene expression between PV patients and healthy controls.

Main Methods:

  • Utilized cDNA microarrays containing 6000 human genes.
  • Analyzed gene expression in granulocytes from 11 PV patients and healthy individuals.

Related Experiment Videos

  • Identified differentially expressed genes using a fold-change threshold of >/==" BORDER="0">2.5.

    • Main Results:

    • 147 genes were significantly up-regulated in the majority of PV patients.
    • Eleven genes exhibited consistent up-regulation across all PV patients, suggesting a molecular signature.
    • Increased expression of protease inhibitors (e.g., cystatin F) and antiapoptotic factors (e.g., adrenomedullin) was observed.

    Conclusions:

    • Specific gene expression alterations in granulocytes are associated with Polycythemia vera.
    • Deregulation of apoptosis-related genes may contribute to abnormal granulocyte survival in PV.
    • Identified gene expression changes offer insights into PV pathophysiology.